Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

CompletedOBSERVATIONAL
Enrollment

399

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

January 23, 2024

Study Completion Date

February 23, 2024

Conditions
Gastroenteropancreatic Neuroendocrine Tumor
Trial Locations (16)

14004

Hospital Universitario Reina Sofia, Córdoba

15706

Hospital Clínico Universitario de Santiago, Santiago de Compostela

17007

Hospital Universitario Dr. Josep Trueta, Girona

28006

Hospital Universitario la Princesa, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Universitario Clínico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario la Paz, Madrid

30120

Hospital Universitario Virgen de la Arrixaca, El Palmar

33011

Hospital Universitario Central de Asturias, Oviedo

33394

Hospital Universitario de Cabueñes, Gijón

39008

Hospital Universitario Marques de Valdecilla, Santander

40026

Hospital Universitari i Poliècnic la Fe, Valencia

46009

Institut Valencià d'Oncologia (IVO), Valencia

50009

Hospital Universitario Miguel Servet, Zaragoza

08035

Hospital Universitario Vall d´Hebron, Barcelona

All Listed Sponsors
lead

Grupo Espanol de Tumores Neuroendocrinos

OTHER

NCT04986085 - Nutrition in Gastroenteropancreatic Neuroendocrine Tumor | Biotech Hunter | Biotech Hunter